06/12/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/12/2020. This one-page letter authorizes the emergency use of the Corneum SARS-CoV-2 Assay, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
No hay comentarios:
Publicar un comentario